CD86 and rheumatoid arthritis: Similarly to RA MØIFN-γ, Sema3B alone did not affect the expression of pro-inflammatory mediators in RA MØM-CSF, but significantly down-regulated the LPS-induced expression of IL12B, besides reducing CD86, TNF and CCL2 (Figure 1B).